These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27766023)

  • 21. Reappraisal of clindamycin IV monotherapy for treatment of mild-to-moderate aspiration pneumonia in elderly patients.
    Kadowaki M; Demura Y; Mizuno S; Uesaka D; Ameshima S; Miyamori I; Ishizaki T
    Chest; 2005 Apr; 127(4):1276-82. PubMed ID: 15821205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacokinetic and clinical studies on sulbactam/ampicillin in the pediatric field].
    Yanagishima M; Yanai M; Yanagi T; Tsuji Y; Nakayama N; Imamura H
    Jpn J Antibiot; 1989 Mar; 42(3):754-65. PubMed ID: 2746855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical effect of ampicillin with beta-lactamase inhibitor (sulbactam/ampicillin) on community-acquired pneumonia in the elderly.
    Okimoto N; Kurihara T; Honda N; Asaoka N; Fujita K; Ohba H; Nakamura J
    J Infect Chemother; 2003 Jun; 9(2):183-6. PubMed ID: 12825120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk evaluation of ampicillin/sulbactam-induced liver injury based on albumin-bilirubin score.
    Ooi H; Asai Y; Sato Y
    J Infect Chemother; 2023 Sep; 29(9):900-904. PubMed ID: 37301371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical efficacy of sulbactam/ampicillin in the field of pediatrics].
    Ogura H; Hisakawa H; Kawakubo K; Kubota H; Shimanouchi Y; Matsumoto K; Tomoda T; Tone Y; Kurashige T
    Jpn J Antibiot; 1989 Mar; 42(3):766-72. PubMed ID: 2746856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Laboratory and clinical studies of sulbactam/ampicillin in pediatric field].
    Nishimura T; Tabuki K; Aoki S; Sugita K; Takagi M
    Jpn J Antibiot; 1989 Mar; 42(3):687-700. PubMed ID: 2746849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of sulbactam-ampicillin/sultamicillin in mixed infections.
    Moosdeen F
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 1():S1. PubMed ID: 10526866
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical evaluation of sulbactam/ampicillin in the pediatric infections].
    Meguro H; Arimasu O; Shiraishi H; Sugamata K; Hiruma F; Abe T; Fujii R; Mashiko J; Nagao Y; Okamoto Y
    Jpn J Antibiot; 1989 Mar; 42(3):612-22. PubMed ID: 2746845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacokinetic, bacteriological and clinical evaluation of sulbactam/ampicillin in pediatrics].
    Hayashi M; Kida K; Matsuda H; Murase M
    Jpn J Antibiot; 1989 Mar; 42(3):743-53. PubMed ID: 2746854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia: Retrospective Comparison Between Intravenous Colistin and Intravenous Ampicillin-Sulbactam.
    Zalts R; Neuberger A; Hussein K; Raz-Pasteur A; Geffen Y; Mashiach T; Finkelstein R
    Am J Ther; 2016; 23(1):e78-85. PubMed ID: 24263165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ampicillin/sulbactam versus cefazolin plus aminoglycosides for antimicrobial prophylaxis in management of Gustilo type IIIA open fractures: A retrospective cohort study.
    Takahara S; Tokura T; Nishida R; Uefuji A; Ichimura K; Nishihara H; Aoki K; Takayama H; Nakagawa N; Harada T
    Injury; 2022 Apr; 53(4):1517-1522. PubMed ID: 35090733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Bacteriological, pharmacokinetic and clinical studies of sulbactam/ampicillin in the pediatric field].
    Haruta T; Kuroki S; Okura K; Yoshioka N; Yamaoka K; Hashimoto H; Kobayashi Y
    Jpn J Antibiot; 1989 Mar; 42(3):719-24. PubMed ID: 2746851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rational antibiotic therapy and the position of ampicillin/sulbactam.
    Lode HM
    Int J Antimicrob Agents; 2008 Jul; 32(1):10-28. PubMed ID: 18539004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical evaluation of sultamicillin fine granules in pediatric patients].
    Ito S; Mayumi M; Mikawa H
    Jpn J Antibiot; 1988 Dec; 41(12):1914-22. PubMed ID: 3249364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Studies on sultamicillin in the field of pediatrics].
    Nakamura H; Miyazu M; Kasai K; Iwai N; Taneda Y
    Jpn J Antibiot; 1988 Dec; 41(12):1874-94. PubMed ID: 3249361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacokinetic and clinical studies on sulbactam/ampicillin in the pediatric field].
    Ito M; Ihara T; Kamiya H; Sakurai M; Shimizu S; Nishi H; Kawaguchi H; Yoshizumi T; Inoue M; Kojima M
    Jpn J Antibiot; 1989 Mar; 42(3):651-61. PubMed ID: 2746848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ceftriaxone versus ampicillin/sulbactam for the treatment of aspiration-associated pneumonia in adults.
    Hasegawa S; Shiraishi A; Yaegashi M; Hosokawa N; Morimoto K; Mori T
    J Comp Eff Res; 2019 Nov; 8(15):1275-1284. PubMed ID: 31736321
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparison of the effects of prophylactic antibiotic therapy and cost-effectiveness between cefazolin (CEZ) and Sulbactam/Ampicillin (SBT/ABPC) in gastric cancer surgery employing clinical pathway].
    Ise Y; Hagiwara K; Saitoh S; Honjo K; Soh S; Kato A; Katayama S; Nishizawa K; Hirano M; Yoshiyuki T; Kiyama T; Mitsuhashi K; Kamei M; Shiragami M
    Yakugaku Zasshi; 2004 Nov; 124(11):815-24. PubMed ID: 15516808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experiences with sultamicillin granules in pediatric patients].
    Iguchi K; Kamiya H; Sakurai M; Shimizu S; Nishi H; Kawaguchi H; Yoshizumi T; Inoue M; Kojima M
    Jpn J Antibiot; 1988 Dec; 41(12):1906-13. PubMed ID: 3249363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sulbactam-containing beta-lactamase inhibitor combinations.
    Akova M
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():185-8. PubMed ID: 18154545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.